发明名称 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
摘要 The invention relates to compounds of formula(I), or a pharmaceutically acceptable salt thereof: Formula (I) which possess inhibitory activity against activating mutant forms of EGFR,and are accordingly useful for their anti-cancer activity and in methods of treatment of the human or animal body. The invention also relates pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti- cancer effect in a warm-blooded animal such as man.
申请公布号 AU2014224382(A1) 申请公布日期 2015.09.03
申请号 AU20140224382 申请日期 2014.03.05
申请人 ASTRAZENECA AB 发明人 LI, DAVID YUNZHI;WANG, JIABING;YANG, ZHENFAN;ZENG, QINGBEI;ZHANG, XIAOLIN
分类号 C07D403/12;A61K31/495;A61K31/505 主分类号 C07D403/12
代理机构 代理人
主权项
地址